Profile data is unavailable for this security.
About the company
Micro-X Limited is an Australia-based company engaged in developing and commercializing a range of products for global health and security markets, based on cold cathode, carbon nanotube (CNT) emitter technology. The electronic control of emitters with this technology enables x-ray products with significant reduction in size, weight, and power requirements, enabling mobility and ease of use in existing x-ray markets and a range of security and defense applications. Its product portfolio spans four, high margin, product applications in health and security. Its segments include Micro-X Limited Australia and Micro-X Inc United States. Its products include Mobile X-Ray Machines, Argus X-Ray Camera, Miniature Baggage Scanner, and Head CT. The Company’s commercial mobile digital radiology products are sold for diagnostic imaging in global healthcare, military, and veterinary applications, and the Argus X-ray Camera for security and defense and is also available commercially.
- Revenue in AUD (TTM)15.17m
- Net income in AUD-14.51m
- Incorporated2011
- Employees--
- LocationMicro-X LtdA14 6 MAB Eastern Promenade1284 South Road, TonsleyADELAIDE 5042AustraliaAUS
- Phone+61 87099-3966
- Websitehttps://micro-x.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Resonance Health Ltd | 5.74m | -1.09m | 23.69m | 18.00 | -- | 2.52 | -- | 4.13 | -0.0025 | -0.0025 | 0.013 | 0.0211 | 0.5077 | -- | 4.93 | -- | -9.61 | -1.60 | -10.51 | -1.71 | -- | -- | -18.93 | -4.00 | -- | -- | 0.0316 | -- | 17.75 | 9.15 | 31.65 | -- | -3.06 | -- |
Lumos Diagnostics Holdings Ltd | 12.56m | -13.49m | 24.07m | -- | -- | 1.71 | -- | 1.92 | -0.0363 | -0.0363 | 0.0357 | 0.0293 | 0.3418 | 2.24 | 6.37 | -- | -36.70 | -40.15 | -55.14 | -56.67 | 59.73 | 45.97 | -107.38 | -162.90 | 0.479 | -6.25 | 0.4803 | -- | -9.42 | 39.29 | 80.38 | -- | -38.50 | -- |
Cleanspace Holdings Ltd | 13.66m | -5.44m | 29.40m | -- | -- | 1.47 | -- | 2.15 | -0.0706 | -0.0706 | 0.1771 | 0.2584 | 0.4523 | 1.10 | 4.85 | -- | -18.02 | -2.29 | -21.72 | -2.90 | 70.40 | 74.09 | -39.83 | -2.76 | 3.72 | -- | 0.1562 | -- | -9.47 | 9.38 | 27.92 | -- | -50.70 | -- |
Respiri Ltd | 794.32k | -6.39m | 34.40m | 2.00 | -- | 9.03 | -- | 43.30 | -0.0074 | -0.0074 | 0.0009 | 0.0033 | 0.1676 | 0.0118 | 2.79 | -- | -134.72 | -179.16 | -219.11 | -301.22 | 97.01 | -- | -803.86 | -640.45 | 1.09 | -78.80 | 0.032 | -- | -15.01 | -5.51 | 12.82 | -- | 22.51 | -- |
BCAL Diagnostics Ltd | 3.67m | -5.00m | 41.09m | -- | -- | 4.77 | -- | 11.18 | -0.0227 | -0.0227 | 0.0166 | 0.0241 | 0.4493 | -- | 3.21 | -- | -61.10 | -54.01 | -67.83 | -62.57 | -- | -- | -136.00 | -248.64 | -- | -131.83 | 0.1985 | -- | 298.63 | 63.18 | -49.51 | -- | 91.62 | -- |
Universal Biosensors, Inc. | 6.81m | -6.39m | 42.47m | 97.00 | -- | 1.87 | -- | 6.24 | -0.0304 | -0.0304 | 0.0315 | 0.0762 | 0.1941 | 0.6025 | 3.61 | -- | -18.23 | -21.79 | -24.51 | -27.14 | 62.97 | 46.16 | -93.90 | -209.31 | 3.02 | -- | 0.0342 | -- | 46.58 | -37.48 | 74.90 | -- | 26.83 | -- |
Micro-X Ltd | 15.17m | -14.51m | 44.20m | -- | -- | 3.95 | -- | 2.91 | -0.0281 | -0.0281 | 0.0294 | 0.0192 | 0.5425 | 0.8518 | 9.08 | -- | -51.87 | -43.99 | -67.43 | -59.14 | 63.58 | 65.04 | -95.61 | -130.78 | 1.28 | -56.11 | 0.3033 | -- | 14.42 | 22.25 | 37.07 | -- | 23.88 | -- |
Curvebeam AI Ltd | 8.78m | -57.55m | 52.48m | 50.00 | -- | 1.63 | -- | 5.98 | -0.18 | -0.18 | 0.0275 | 0.1477 | 0.1347 | 0.5618 | 3.47 | -- | -88.33 | -- | -115.31 | -- | 48.78 | -- | -655.67 | -- | 1.97 | -3.10 | 0.2364 | -- | 381.77 | -- | -509.11 | -- | -- | -- |
Nova Eye Medical Ltd | 18.70m | -14.31m | 54.92m | 130.00 | -- | 2.76 | -- | 2.94 | -0.0797 | -0.0797 | 0.102 | 0.087 | 0.6805 | 0.4822 | 8.34 | -- | -52.10 | -12.19 | -64.18 | -14.93 | 90.20 | 82.04 | -76.56 | -60.21 | 0.8106 | -- | 0.0666 | -- | 27.71 | -26.42 | -104.02 | -- | -28.45 | -- |
Compumedics Limited | 49.62m | 1.23m | 55.13m | 135.00 | 42.13 | 2.95 | 21.52 | 1.11 | 0.0071 | 0.0071 | 0.3107 | 0.1018 | 1.24 | 2.14 | 4.43 | 367,540.80 | 3.07 | -2.91 | 6.53 | -4.63 | 53.54 | 53.44 | 2.48 | -2.90 | 0.7483 | 2.01 | 0.3385 | -- | 12.32 | 2.76 | -551.14 | -- | 16.84 | -- |
Holder | Shares | % Held |
---|---|---|
Perennial Value Management Ltd.as of 27 Feb 2024 | 60.63m | 10.43% |
Acorn Capital Ltd.as of 17 Aug 2023 | 45.10m | 7.76% |
Thorney Investment Group Australia Pty Ltd.as of 17 Aug 2023 | 26.28m | 4.52% |
AustralianSuper Pty Ltd.as of 14 Dec 2022 | 23.81m | 4.10% |
Norges Bank Investment Managementas of 31 Dec 2023 | 15.54m | 2.67% |
Gowing Bros. Ltd. (Investment Management)as of 17 Aug 2023 | 2.75m | 0.47% |
Quadriga Asset Managers SGIIC SAas of 31 Dec 2023 | 1.30m | 0.22% |
DFA Australia Ltd.as of 30 Jun 2024 | 312.42k | 0.05% |
Dimensional Fund Advisors LPas of 30 Apr 2024 | 261.66k | 0.05% |